New experimental rabbit animal model for cervical spondylotic myelopathy

Spinal Cord

Volumn 49, Issue 11, 2011, Pages 1097-1102

  Klironomos, G ^a   Karadimas, S ^a   Mavrakis, A ^a   Mirilas, P ^b   Savvas, I ^b   Papadaki, E ^a   Papachristou, D J ^a,c   Gatzounis, G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

animal model; CSM; pathogenesis

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN; NEUROFILAMENT PROTEIN; PROTEIN S 100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERVICAL MYELOPATHY; CERVICAL SPONDYLOTIC MYELOPATHY; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; EDEMA; EPIDURAL SPACE; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; MICROENVIRONMENT; MICROSURGERY; MOTOR PERFORMANCE; NEUROPATHOLOGY; NONHUMAN; OSTEOPHYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SPINAL CORD COMPRESSION; SWELLING;

ANIMALS; CERVICAL VERTEBRAE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ETHERS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; NEUROFILAMENT PROTEINS; PROSTHESES AND IMPLANTS; RABBITS; S100 PROTEINS; SPINAL CORD; SPINAL CORD COMPRESSION; SPONDYLOSIS;

EID: 80455164671     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2011.71     Document Type: Article

References (21)

1. Imai T. Cervical spondylotic myelopathy and sagittal diameter of the cervical canal]. Nippon Seikeigeka Gakkai Zasshi 1970; 44: 429-438.
2. White III AA, Panjabi MM. Biomechanical considerations in the surgical management of cervical spondylotic myelopathy. Spine 1988; 13: 856-860.
3. Robinson RA, Afeiche N, Dunn EJ, Northrup BE. Cervical spondylotic myelopathy: etiology and treatment concepts. Spine 1977; 2: 89-99. (Pubitemid 8156035)
4. Baptiste DC, Fehlings MG. Pathophysiology of cervical myelopathy. Spine J 2006; 6: 190S-197S.
5. Barron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology clinical course, and diagnosis. Neurosurgery 2007; 60(1 Supp1 1): S35-S41.
6. Barnes MP, Saunders M. The effect of cervical mobility on the natural history of cervical spondylotic myelopathy. J Neurol Neurosurg Psychiatry 1984; 47: 17-20. (Pubitemid 14154233)
7. Hogan El, Romanul FCA. Spinal cord infarction occurring during insertion of aortic graft. Neurology 1966; 16: 67-74.
8. Mair WGP, Druckman R. The pathology of spinal cord lesions and their relation to the clinical features in protrusion of cervical intervertebral discs (a report of four cases). Brain 1953; 76: 70-91.
9. Karadimas SK, Gialeli CH, Klironomos G, Tzanakakis GN, Panagiotopoulos E, Karamanos NK et al. The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy. Curr Med Chem 2010; 17: 1048-1058.
10. Tyllianakis M, Dalas E, Christofidou M, Kallitsis JK, Chrissanthopoulos A, Koutsoukos PG et al. Novel composites materials from functionalized polymers and silver coated titanium oxide capable for calcium phosphate induction, control of orthopedic biofilm infections: an in vitro study. J Mater Sci Mater Med 2010; 21: 2201-2211.
11. Ito T, Oyanagi K, Takahashi H, Takahashi HE, Ikuta F. Cervical spondylosis myelopathy: clinicopathologic study on the progression pattern and thin myelinated fibers of the lesions of seven patients examined during complete autopsy. Spine 1996; 21: 827-833. (Pubitemid 26112354)
12. Ogino H, Tada K, Okada K, Yonenobu K, Yamamoto T, Ono K et al. Canal diameter, antero-posterior compression ratio, and spondylotic myelopathy of the cervical spine. Spine 1983; 8: 1-15. (Pubitemid 13092421)
13. Payne LW, Spillane JD. The cervical spine, an anatomical study of specimens, with particular reference to the problem of cervical spondylosis. Brain 1957; 80: 571-596.
14. Fehlings MG, Yu WR, Shannon P, Sekhon LHS. Molecular mechanisms of cell death in human cervical spondylotic myelopathy: evidence for apoptosis, death receptor expression and Caspase 3 activation. Proceedings of the 28th Annual Meeting of the Cervical Spine Research Society 2000.
15. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-156. (Pubitemid 38160289)
16. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20: 570-577. (Pubitemid 27508969)
17. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammationinduced secondary injury after CNS trauma. J Neurosci 1999; 19: 8182-8198. (Pubitemid 30226738)
18. McGraw J, Hiebert GW, Steeves JD. Modulating astrogliosis after neurotrauma. J Neurosci Res 2001; 63: 109-115. (Pubitemid 32041861)
19. Matyash M, Matyash V, Nolte C, Sorrentino V, Kettenmann H. Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J 2002; 16: 84-86.
20. Kim P, Haisa T, Kawamoto T, Kirino T, Wakai S. Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann Neurol 2004; 55: 503-511. (Pubitemid 38391967)
21. Kanchiku T, Taguchi T, Kaneko K, Yonemura H, Kawai S, Gondo T. A new rabbit model for the study on cervical compressive myelopathy. J Orthop Res 2001; 19: 605-613. (Pubitemid 32700975)